In the aforementioned study by Sklar et al., there were 15 subsequent neoplasm (SN) that occurred after start of GH therapy, all of which were solid tumors, and 14 occurred at a site previously exposed to external radiation or after treatment with alkylating agents. This evidence concerns the gene GH1 and neoplasm.